{
  "ticker": "VRTX",
  "year": 2025,
  "quarter": 1,
  "last_updated": "2025-04-19T09:36:19.551340",
  "count": 62,
  "transactions": [
    {
      "id": 268424,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2025-02-26",
      "transaction_shares": "5954",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "34246"
    },
    {
      "id": 268430,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2025-02-26",
      "transaction_shares": "4962",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "32669"
    },
    {
      "id": 268453,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2025-02-26",
      "transaction_shares": "2482",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "22002"
    },
    {
      "id": 268458,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2025-02-26",
      "transaction_shares": "3703",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "68490"
    },
    {
      "id": 268468,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2025-02-26",
      "transaction_shares": "7071",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "62935"
    },
    {
      "id": 268482,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2025-02-26",
      "transaction_shares": "1241",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "7845"
    },
    {
      "id": 268489,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2025-02-26",
      "transaction_shares": "14079",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "105915"
    },
    {
      "id": 268502,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2025-02-26",
      "transaction_shares": "4962",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "59069"
    },
    {
      "id": 268525,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-02-26",
      "transaction_shares": "4962",
      "transaction_price": "479.61",
      "transaction_type": "F",
      "shares_after_transaction": "54969"
    },
    {
      "id": 268425,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2025-02-24",
      "transaction_shares": "3310",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "37631"
    },
    {
      "id": 268443,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2025-02-24",
      "transaction_shares": "4716",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "70006"
    },
    {
      "id": 268484,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-02-24",
      "transaction_shares": "3310",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "59931"
    },
    {
      "id": 268506,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2025-02-24",
      "transaction_shares": "3310",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "64385"
    },
    {
      "id": 268511,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2025-02-24",
      "transaction_shares": "3971",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "41048"
    },
    {
      "id": 268520,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2025-02-24",
      "transaction_shares": "828",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "9970"
    },
    {
      "id": 268522,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2025-02-24",
      "transaction_shares": "2470",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "72193"
    },
    {
      "id": 268549,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2025-02-24",
      "transaction_shares": "9386",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "119994"
    },
    {
      "id": 268569,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2025-02-24",
      "transaction_shares": "1656",
      "transaction_price": "483.28",
      "transaction_type": "F",
      "shares_after_transaction": "26251"
    },
    {
      "id": 268537,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2025-02-20",
      "transaction_shares": "1111",
      "transaction_price": "480",
      "transaction_type": "S",
      "shares_after_transaction": "45019"
    },
    {
      "id": 268469,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2025-02-14",
      "transaction_shares": "564",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "11469"
    },
    {
      "id": 268471,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2025-02-14",
      "transaction_shares": "6066",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "24026"
    },
    {
      "id": 268479,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2025-02-14",
      "transaction_shares": "1504",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "19263"
    },
    {
      "id": 268499,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2025-02-14",
      "transaction_shares": "2139",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "74663"
    },
    {
      "id": 268505,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2025-02-14",
      "transaction_shares": "1912",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "40941"
    },
    {
      "id": 268534,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2025-02-14",
      "transaction_shares": "1529",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "27907"
    },
    {
      "id": 268536,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-02-14",
      "transaction_shares": "2293",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "63241"
    },
    {
      "id": 268552,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2025-02-14",
      "transaction_shares": "2293",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "67939"
    },
    {
      "id": 268556,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2025-02-14",
      "transaction_shares": "2724",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "74722"
    },
    {
      "id": 268557,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2025-02-14",
      "transaction_shares": "2293",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "46130"
    },
    {
      "id": 268561,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2025-02-14",
      "transaction_shares": "6553",
      "transaction_price": "463.46",
      "transaction_type": "F",
      "shares_after_transaction": "129380"
    },
    {
      "id": 268431,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2025-02-12",
      "transaction_shares": "6211",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "70232"
    },
    {
      "id": 268433,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2025-02-12",
      "transaction_shares": "7209",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "32617"
    },
    {
      "id": 268455,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2025-02-12",
      "transaction_shares": "6211",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76802"
    },
    {
      "id": 268462,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "2080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12033"
    },
    {
      "id": 268504,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "5324",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "48423"
    },
    {
      "id": 268509,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "6655",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65534"
    },
    {
      "id": 268516,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2025-02-12",
      "transaction_shares": "19015",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "135933"
    },
    {
      "id": 268529,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2025-02-12",
      "transaction_shares": "6211",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "29436"
    },
    {
      "id": 268533,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "4437",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "20767"
    },
    {
      "id": 268538,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2025-02-12",
      "transaction_shares": "5546",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "42853"
    },
    {
      "id": 268571,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2025-02-12",
      "transaction_shares": "7903",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "77446"
    },
    {
      "id": 268467,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-02-10",
      "transaction_shares": "2649",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "58879"
    },
    {
      "id": 268483,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2025-02-10",
      "transaction_shares": "2056",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "70591"
    },
    {
      "id": 268496,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2025-02-10",
      "transaction_shares": "2142",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "43099"
    },
    {
      "id": 268512,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2025-02-10",
      "transaction_shares": "2143",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "64331"
    },
    {
      "id": 268513,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2025-02-10",
      "transaction_shares": "876",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "24972"
    },
    {
      "id": 268514,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2025-02-10",
      "transaction_shares": "1632",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "19763"
    },
    {
      "id": 268543,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2025-02-10",
      "transaction_shares": "8300",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "116918"
    },
    {
      "id": 268544,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2025-02-10",
      "transaction_shares": "3220",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "69543"
    },
    {
      "id": 268568,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2025-02-10",
      "transaction_shares": "2142",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "37307"
    },
    {
      "id": 268575,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2025-02-10",
      "transaction_shares": "591",
      "transaction_price": "467.98",
      "transaction_type": "F",
      "shares_after_transaction": "11329"
    },
    {
      "id": 268438,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2025-02-04",
      "transaction_shares": "29118",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "104890"
    },
    {
      "id": 268444,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "10262",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "33521"
    },
    {
      "id": 268464,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "2566",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10066"
    },
    {
      "id": 268465,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2025-02-04",
      "transaction_shares": "5132",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21104"
    },
    {
      "id": 268474,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "14624",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64315"
    },
    {
      "id": 268475,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "12314",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "38127"
    },
    {
      "id": 268477,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "4744",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21395"
    },
    {
      "id": 268493,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2025-02-04",
      "transaction_shares": "15414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25408"
    },
    {
      "id": 268528,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2025-02-04",
      "transaction_shares": "8210",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65533"
    },
    {
      "id": 268532,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "10262",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "54414"
    },
    {
      "id": 268539,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2025-02-04",
      "transaction_shares": "10262",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "59360"
    }
  ]
}